查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1972091

毛細血管和靜脈採血設備市場：按設備類型、技術、檢體類型、採血部位、形態、年齡層、最終用戶、應用和配銷通路分類——全球預測，2026-2032年

Capillary & Venous Blood Sampling Device Market by Device Type, Technology, Sample Type, Sample Site, Format, Age Group, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，毛細血管和靜脈採血設備市場價值將達到 27.9 億美元，到 2026 年將成長至 30.2 億美元，到 2032 年將達到 49.8 億美元，複合年成長率為 8.61%。

主要市場統計數據
基準年 2025 27.9億美元
預計年份：2026年 30.2億美元
預測年份：2032年 49.8億美元
複合年成長率 (%) 8.61%

臨床和技術環境的演變正在重塑醫療保健環境中採樣設備的使用方式，並重新定義製造商和供應商的優先事項。

由於臨床實踐、監管要求和分銷管道的同步發展，毛細血管和靜脈採血設備市場正處於轉型期。這些設備傳統上僅限於檢查室和醫院靜脈採血室，如今在更廣泛的醫療服務中發揮核心作用，應用範圍涵蓋臨床檢測、照護現場診斷和家庭監測。隨著臨床團隊將患者體驗和營運效率置於優先地位，設備性能特徵（例如檢體完整性、易用性和與下游分析儀器的兼容性）已成為採購決策的首要考慮因素。

檢測的快速分散化、對感染控制的日益重視以及法規的明確，正在推動設備設計和臨床部署發生重大變化。

過去幾年，變革性的變化徹底改變了醫療保健系統中血液採集設備的研發、採購和部署方式。隨著診斷功能從臨床環境轉移到患者家中，人們對簡單、耐用且易於使用的設備的需求日益成長。過去需要經過培訓的血液採集技術人員操作的設備，如今正在重新設計，以便護士、看護者和患者本人都能使用，這使得血液採集流程更加注重直覺的界面、清晰的操作說明和錯誤預防措施。

2025 年貿易政策的轉變促使供應鏈進行大規模調整，重組了採購方式、採購重點和產品設計決策。

2025年實施的關稅以及不斷變化的貿易政策措施，已經改變了毛細血管和靜脈採血設備製造商和經銷商的供應鏈格局，對採購、產品設計和籌資策略等各個環節都產生了累積影響。依賴進口零件的製造商面臨著不斷上漲的到岸成本，被迫修改供應商合約和庫存管理政策。為此，許多企業加快了供應商多元化進程，評估了近岸外包機會，並優先考慮雙重採購安排，以降低關稅波動帶來的風險。

多維細分框架將儀器類型、最終用戶、應用、技術、檢體特徵和分銷管道連結起來，指南策略性產品類型和商業性優先順序。

精細的細分分析揭示了每種設備類型、最終用戶、應用、技術、檢體類型、採集部位、形態、分銷管道和患者年齡層的不同機會和風險。按設備類型分類，毛細管解決方案針對最小樣本量進行了最佳化，而靜脈系統則旨在獲取多種分析物並進行大容量採集，兩者之間存在著顯著差異，各自需要獨特的耗材和介面設計。按最終用戶分類，診所、診斷實驗室、居家醫療和醫院各自面臨不同的營運限制。診所必須在處理能力和患者體驗之間取得平衡，並涵蓋了普通診所和專科診所。檢查室需要與醫院或獨立檢查室的工作流程整合。居家醫療強調操作的便利性，無論是護士輔助的患者還是自我管理的患者。醫院則涵蓋了普通病房和專科病房，其手術複雜程度各不相同。

醫療服務模式、監管要求和供應鏈基礎設施方面的區域差異，需要為每個地區量身定製商業策略。

區域趨勢對需求集中地點、供應鏈建構方式以及臨床應用案例的增加都有顯著影響。在美洲，醫療保健系統重視能夠部署於大規模醫院網路和社區診所的高度可擴展解決方案，尤其關注互通性、報銷管道和檢查室整合。此外，人們對居家檢測方法的興趣日益濃厚，並積極尋求夥伴關係，以便在不同的醫療保健環境中快速部署這些方法。

競爭對手正利用產品模組化、垂直整合和臨床夥伴關係來確保採購交易並加強與客戶的長期關係。

採樣設備領域的主要企業正透過產品創新、供應鏈管理以及與診斷測試開發公司和臨床網路建立策略合作夥伴關係來實現差異化競爭。市場領導正投資人體工學設計以減少使用者操作失誤，並開發模組化平台以實現分析試劑盒和輔助耗材的快速安裝。一些競爭對手正在尋求垂直整合，以確保關鍵耗材的供應，並減輕零件關稅和物流限制的影響。

為製造商和買家提供切實可行的策略措施，以增強韌性、加速推廣應用，並提高在各種臨床管道中的商業性競爭力。

產業領導者應採取一系列協調一致的行動，以應對臨床需求、日益嚴格的監管和供應鏈風險之間錯綜複雜的相互作用。首先，應優先考慮人性化的設計和經實踐驗證的易用性，以加快在護理人員輔助和自我監測環境中的部署，並確保標識和說明材料能夠滿足不同語言和識字水平的需求。其次，應建構具韌性的供應商網路，結合在地採購和策略性庫存緩衝，以最佳化到岸成本，同時降低貿易政策的影響力。

本研究採用多面向方法，結合相關人員訪談、實際設備評估和二次檢驗，得出實用且經過嚴格檢驗的策略見解。

為確保研究結果的穩健性和相關性，本研究結合了實地研究、結構化的二手分析和質性檢驗。主要方法包括對醫院、檢查室、診所和居家照護機構的臨床相關人員進行詳細訪談，以及與採購經理和供應鏈經理進行對話，以了解商業性因素。此外，也透過實際設備和人體工學評估，觀察實際使用環境中的操作性和預分析工作流程，從而收集一手資訊。

綜合研究結果表明，人性化的產品設計、穩健的採購和協作式商業化這三個要素緊密相連，是未來成功的關鍵。

總而言之，毛細血管和靜脈採血設備的市場格局呈現出以下特點：檢測流程的快速分散化、對易用性和安全性的期望不斷提高，以及貿易夥伴關係導致的供應鏈複雜性。成功取決於產品設計能否與實際臨床工作流程相契合、能否建立穩固的採購基礎，以及能否在不同的醫療環境中展現其監管和營運價值。隨著診斷工作流程不斷從中心化檢查室轉移，那些投資於人性化的設計、策略合作和靈活商業化模式的公司，將更有利於實現長期市場認可。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：毛細血管和靜脈採血設備市場：依設備類型分類

  • 微血管
  • 靜脈

第9章：毛細血管和靜脈採血設備市場：依技術分類

  • 自動的
  • 手動的
  • 照護現場

第10章：毛細血管和靜脈採血裝置市場：依檢體類型分類

  • 電漿
  • 血清
  • 全血

第11章 毛細血管和靜脈採血裝置市場：依採血部位分類

  • 指尖穿刺
  • 腳跟刺傷
  • 靜脈穿刺

第12章 毛細血管和靜脈採血裝置市場：依形式分類

  • 可重複使用的
  • 一次性

第13章：毛細血管和靜脈採血設備市場：依年齡層別分類

  • 成人
  • 老年人
  • 兒童

第14章 毛細血管和靜脈採血裝置市場：依最終用戶分類

  • 診所
    • 一般診所
    • 專科診所
  • 診斷實驗室
    • 醫院檢查室
    • 獨立測試機構
  • 居家照護
    • 護理助理
    • 自我管理
  • 醫院
    • 綜合醫院
    • 專科醫院

第15章：毛細血管和靜脈採血裝置市場：依應用分類

  • 用於診斷
    • 心臟檢查
    • 糖尿病檢測
  • 監測
    • 慢性病監測
    • 妊娠監測
  • 研究
    • 學術研究
    • 臨床試驗

第16章：毛細血管和靜脈採血設備市場：依通路分類

  • 直銷
    • 企業客戶的銷售
    • 線上銷售
  • 銷售代理
    • 全國銷售代理
    • 區域銷售代理

第17章 毛細血管及靜脈採血設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第18章：毛細血管及靜脈採血設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第19章 毛細血管和靜脈採血裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第20章：美國毛細血管及靜脈採血設備市場

第21章：中國毛細血管及靜脈採血設備市場

第22章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Drawbridge Health, Inc.
  • Greiner Bio-One International GmbH
  • Nipro Corporation
  • Poly Medicure Limited
  • Radiometer Medical ApS
  • Roche Diagnostics International AG
  • Sarstedt AG & Co. KG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-2B5802CFEB42

The Capillary & Venous Blood Sampling Device Market was valued at USD 2.79 billion in 2025 and is projected to grow to USD 3.02 billion in 2026, with a CAGR of 8.61%, reaching USD 4.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.79 billion
Estimated Year [2026] USD 3.02 billion
Forecast Year [2032] USD 4.98 billion
CAGR (%) 8.61%

An evolving clinical and technological environment is reshaping sampling device use across care settings and redefining priorities for manufacturers and providers

The capillary and venous blood sampling device landscape is at an inflection point driven by simultaneous advances in clinical practice, regulatory expectations, and channel evolution. Historically confined to laboratories and hospital phlebotomy suites, these devices are now central to a broader continuum of care that spans clinic-based testing, point-of-care diagnostics, and in-home monitoring. As clinical teams prioritize patient experience and operational efficiency, device performance characteristics such as sample integrity, ease of use, and compatibility with downstream analytics have risen to the forefront of procurement decisions.

Moreover, technological progress in microfluidics, automation, and integrated cartridge systems has expanded the functional envelope of sampling devices, enabling higher throughput and improved safety for both capillary and venous procedures. Simultaneously, healthcare systems are recalibrating workflows to support decentralized testing paradigms while preserving clinical quality controls and regulatory compliance. This dynamic environment demands that manufacturers, distributors, and healthcare providers re-evaluate product design, training, and supply chain strategies to sustain clinical reliability and drive adoption across diverse care settings.

Rapid decentralization of testing, heightened infection control priorities, and regulatory clarity are driving major shifts in device design and clinical adoption

In the past several years, transformative shifts have redefined how blood sampling devices are developed, procured, and deployed across health systems. The migration of diagnostic capabilities toward the point of care and patient homes has elevated requirements for device simplicity, robustness, and usability. Devices that once needed trained phlebotomists to operate are being reengineered for use by nursing staff, caregivers, and patients themselves, which in turn has increased emphasis on intuitive interfaces, clear instructions for use, and error-proofing of collection workflows.

Simultaneously, heightened infection control priorities and single-use preferences accelerated by public health events have influenced adoption patterns, prompting manufacturers to weigh the trade-offs between reusable systems and disposable formats. Advances in automation and sample processing have enabled integration with laboratory information systems, improving traceability and reducing pre-analytical errors. At the same time, regulatory agencies have signaled clearer expectations around device validation, stability data for different sample types such as plasma and serum, and human factors engineering. These combined shifts are catalyzing cross-industry collaboration between device makers, diagnostic developers, and clinical networks to deliver solutions that are both clinically rigorous and operationally scalable.

Trade policy shifts in 2025 prompted sweeping supply chain adaptations that reshaped sourcing practices, procurement priorities, and product design decisions

The imposition of tariffs and evolving trade policy measures in the United States during 2025 have altered supply chain calculus for manufacturers and distributors of capillary and venous blood sampling devices, with cumulative effects felt across procurement, product design, and sourcing strategies. Producers dependent on imported components confronted rising landed costs that required reassessment of supplier contracts and inventory policies. In response, many organizations accelerated supplier diversification, evaluated nearshoring opportunities, and prioritized dual-sourcing arrangements to reduce exposure to tariff volatility.

Buyers, particularly in institutional settings, began to reassess total cost of ownership rather than unit price alone, factoring in logistics overheads, customs delays, and the risk of intermittent supply shortages. For device developers, these pressures intensified incentives to redesign devices for lower-cost localizable components or to consolidate component suppliers to achieve economies of scale. At the distribution layer, margins compressed where tariff impacts could not be fully passed to end users, prompting renegotiations of commercial terms and selective withdrawal from low-margin segments.

Importantly, tariff-driven realignment also had indirect effects on innovation and market entry. New entrants and smaller suppliers faced higher barriers due to increased initial capital requirements and supply chain complexity, while established players with integrated manufacturing footprints leveraged scale to sustain competitive positioning. Overall, the cumulative tariff environment encouraged resilience planning across the value chain, prompting investments in domestic manufacturing capability, deeper supplier relationships, and more robust scenario-based procurement frameworks.

A multidimensional segmentation framework links device types, end users, applications, technologies, sample attributes, and channels to inform strategic product and commercial prioritization

A nuanced segmentation lens reveals differentiated opportunity and risk across device types, end users, applications, technologies, sample types, sample sites, formats, distribution channels, and patient age groups. When viewed by device type, the landscape bifurcates between capillary solutions optimized for minimal volume collection and venous systems designed for broader analyte access and higher volume requirements, each demanding unique consumable and interface design considerations. Across end users, clinics, diagnostic laboratories, home care, and hospitals present distinct operational constraints; clinics balance throughput with patient experience and include both general clinics and specialized clinics, laboratories require integration with hospital or independent lab workflows, home care emphasizes nurse-aided and self-monitoring usability, and hospitals incorporate both general and specialty units with varying procedure complexity.

Application-driven differentiation further refines market focus. Diagnostic use spans cardiac and diabetes testing, where pre-analytical stability and accurate sample handling are paramount; monitoring applications concentrate on chronic disease and pregnancy tracking that require repeatability and convenience; research activities subdivide into academic investigations and clinical trials with heightened regulatory and chain-of-custody demands. Technology choices-automated, manual, or point of care-directly impact training, capital investment, and integration needs. Sample type selection among plasma, serum, and whole blood influences processing workflows and downstream assay compatibility, while sample site considerations such as fingerstick, heel stick, and venipuncture determine device ergonomics and patient tolerability. Format options between reusable and single-use devices affect lifecycle costs, sterilization protocols, and sustainability assessments. Distribution channels split between direct sales and distributors, with direct sales differentiated by corporate and online channels and distributors ranging from national to regional partners, each channel carrying implications for service, support, and inventory management. Finally, age group segmentation across adult, geriatric, and pediatric cohorts introduces clinical and ergonomic requirements that shape device design, consumable sizing, and labeling practices. Taken together, these segmentation vectors provide a multidimensional framework for prioritizing product development, regulatory strategy, and commercial deployment.

Regional variations in care delivery models, regulatory expectations, and supply chain infrastructure demand tailored commercial strategies for each geography

Regional dynamics are materially influencing where demand concentrates, how supply chains are organized, and which clinical use cases gain traction. In the Americas, health systems emphasize scalable solutions that can be deployed across large hospital networks and community clinics, with particular attention to interoperability, reimbursement pathways, and laboratory integration. This region also shows accelerated interest in home-based testing modalities, and an appetite for partnerships that enable rapid deployment across diverse care settings.

In Europe, the Middle East, and Africa, regulatory harmonization efforts alongside diverse payer models create both opportunities and complexity for manufacturers. Buyers in this region often require stringent demonstrable compliance with local standards and value evidence that aligns with national health priorities. Distribution models vary widely across countries, necessitating adaptable channel strategies and localized service capabilities. In the Asia-Pacific region, growth is driven by a combination of rising healthcare access, investments in diagnostic infrastructure, and strong government-led initiatives to expand primary care capabilities. Local manufacturing hubs and a competitive supplier base contribute to cost-competitive sourcing, while varying clinical practices create demand for devices optimized to local sample types and settings. Collectively, these regional distinctions call for tailored commercial approaches that reconcile global product platforms with targeted local adaptations.

Competitors are leveraging product modularity, vertical integration, and clinical partnerships to secure procurement wins and strengthen long-term customer relationships

Leading companies in the sampling device ecosystem are differentiating through a mix of product innovation, supply chain control, and strategic partnerships with diagnostic test developers and clinical networks. Market leaders invest in human factors engineering to reduce user error and in modular platforms that enable rapid attachment of analytics cartridges or ancillary consumables. Several competitors have pursued vertical integration to secure critical consumables and mitigate the effects of component tariffs and logistics constraints.

Strategic partnerships with laboratory service providers and point-of-care diagnostic manufacturers have become a common route to accelerate adoption, as aligning sampling device design with end-to-end diagnostic workflows reduces friction at procurement and deployment. Service and maintenance capabilities also provide competitive advantage, especially in institutional channels where uptime and batch processing efficiency matter. Additionally, companies that offer robust training programs, digital support tools, and lifecycle management services tend to foster stronger long-term customer relationships. Finally, R&D focus areas among leading companies include enhanced sample stability, contamination control, and designs that reduce the need for cold chain logistics, all of which respond directly to operational pain points identified by clinical users.

Practical strategic moves for manufacturers and buyers to strengthen resilience, drive adoption, and improve commercial competitiveness across diverse clinical pathways

Industry leaders should adopt a coordinated set of actions to navigate the complex interplay of clinical demand, regulatory rigor, and supply chain risk. First, prioritize human-centered design and validated ease-of-use to accelerate adoption across nurse-aided and self-monitoring contexts, ensuring labeling and instructional materials address language and literacy diversity. Second, establish resilient supplier networks that combine local sourcing with strategic inventory buffers to reduce exposure to trade policy shocks while optimizing landed cost.

Third, align product roadmaps with key clinical use cases such as diabetes and cardiac diagnostic workflows, and invest in interoperability with laboratory information systems to simplify procurement conversations with institutional buyers. Fourth, pursue partnerships with diagnostic developers and clinical networks to co-develop integrated solutions that reduce friction at deployment and enhance clinical utility. Fifth, build a differentiated service offering that includes training, after-sales support, and lifecycle management to protect margins and strengthen customer loyalty. Sixth, incorporate sustainability considerations into product design by evaluating reusable versus disposable trade-offs and by optimizing packaging to reduce logistics weight and waste. Finally, enhance regulatory and quality functions to accelerate approvals across diverse jurisdictions and to generate the real-world evidence needed to support payer engagement and clinical adoption.

A multi-method research design combined stakeholder interviews, hands-on device evaluations, and secondary validation to produce actionable and rigorously validated strategic insights

The research underpinning these insights combined primary fieldwork with structured secondary analysis and qualitative validation to ensure robustness and relevance. Primary methods included in-depth interviews with clinical stakeholders across hospital, laboratory, clinic, and home care settings, complemented by conversations with procurement leaders and supply chain managers to understand commercial drivers. Additional primary inputs were obtained from hands-on device evaluations and human factors assessments to observe real-world usability and pre-analytical workflows.

Secondary research surveyed regulatory guidance documents, standards for sample handling and device validation, and publicly available technical literature on automation and microfluidic approaches. Data triangulation occurred through cross-referencing interview findings with technical specifications, regulatory filings, and device labeling to identify consistent themes and validate observed trends. Finally, scenario analysis and expert panel review refined interpretations around trade policy impacts and regional differentiation, enabling the translation of qualitative evidence into actionable insights for product, supply chain, and go-to-market strategies.

Consolidating research insights points to the critical nexus of human-centered product design, resilient sourcing, and collaborative commercialization as keys to future success

In summary, the capillary and venous blood sampling device landscape is characterized by rapid decentralization of testing, heightened expectations for usability and safety, and intensified supply chain complexity driven by trade dynamics. Success will hinge on a company's ability to harmonize product design with real-world clinical workflows, secure resilient sourcing, and demonstrate regulatory and operational value across diverse care settings. Those who invest in human-centered design, strategic partnerships, and flexible commercialization models will be best positioned to capture long-term adoption as diagnostic workflows continue to migrate beyond centralized laboratories.

Looking forward, leaders must balance near-term operational resilience with long-term innovation that embraces automation, integration, and sustainability. By doing so, they can deliver clinically robust sampling solutions that meet the evolving needs of patients, providers, and payers while maintaining commercial agility amid shifting policy and regional dynamics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Capillary & Venous Blood Sampling Device Market, by Device Type

  • 8.1. Capillary
  • 8.2. Venous

9. Capillary & Venous Blood Sampling Device Market, by Technology

  • 9.1. Automated
  • 9.2. Manual
  • 9.3. Point Of Care

10. Capillary & Venous Blood Sampling Device Market, by Sample Type

  • 10.1. Plasma
  • 10.2. Serum
  • 10.3. Whole Blood

11. Capillary & Venous Blood Sampling Device Market, by Sample Site

  • 11.1. Fingerstick
  • 11.2. Heel Stick
  • 11.3. Venipuncture

12. Capillary & Venous Blood Sampling Device Market, by Format

  • 12.1. Reusable
  • 12.2. Single Use

13. Capillary & Venous Blood Sampling Device Market, by Age Group

  • 13.1. Adult
  • 13.2. Geriatric
  • 13.3. Pediatric

14. Capillary & Venous Blood Sampling Device Market, by End User

  • 14.1. Clinic
    • 14.1.1. General Clinic
    • 14.1.2. Specialized Clinic
  • 14.2. Diagnostic Laboratory
    • 14.2.1. Hospital Laboratory
    • 14.2.2. Independent Laboratory
  • 14.3. Home Care
    • 14.3.1. Nurse Aided
    • 14.3.2. Self Monitoring
  • 14.4. Hospital
    • 14.4.1. General Hospital
    • 14.4.2. Specialty Hospital

15. Capillary & Venous Blood Sampling Device Market, by Application

  • 15.1. Diagnostic
    • 15.1.1. Cardiac Testing
    • 15.1.2. Diabetes Testing
  • 15.2. Monitoring
    • 15.2.1. Chronic Disease Monitoring
    • 15.2.2. Pregnancy Monitoring
  • 15.3. Research
    • 15.3.1. Academic Research
    • 15.3.2. Clinical Trials

16. Capillary & Venous Blood Sampling Device Market, by Distribution Channel

  • 16.1. Direct Sales
    • 16.1.1. Corporate Sales
    • 16.1.2. Online Sales
  • 16.2. Distributors
    • 16.2.1. National Distributor
    • 16.2.2. Regional Distributor

17. Capillary & Venous Blood Sampling Device Market, by Region

  • 17.1. Americas
    • 17.1.1. North America
    • 17.1.2. Latin America
  • 17.2. Europe, Middle East & Africa
    • 17.2.1. Europe
    • 17.2.2. Middle East
    • 17.2.3. Africa
  • 17.3. Asia-Pacific

18. Capillary & Venous Blood Sampling Device Market, by Group

  • 18.1. ASEAN
  • 18.2. GCC
  • 18.3. European Union
  • 18.4. BRICS
  • 18.5. G7
  • 18.6. NATO

19. Capillary & Venous Blood Sampling Device Market, by Country

  • 19.1. United States
  • 19.2. Canada
  • 19.3. Mexico
  • 19.4. Brazil
  • 19.5. United Kingdom
  • 19.6. Germany
  • 19.7. France
  • 19.8. Russia
  • 19.9. Italy
  • 19.10. Spain
  • 19.11. China
  • 19.12. India
  • 19.13. Japan
  • 19.14. Australia
  • 19.15. South Korea

20. United States Capillary & Venous Blood Sampling Device Market

21. China Capillary & Venous Blood Sampling Device Market

22. Competitive Landscape

  • 22.1. Market Concentration Analysis, 2025
    • 22.1.1. Concentration Ratio (CR)
    • 22.1.2. Herfindahl Hirschman Index (HHI)
  • 22.2. Recent Developments & Impact Analysis, 2025
  • 22.3. Product Portfolio Analysis, 2025
  • 22.4. Benchmarking Analysis, 2025
  • 22.5. 3M Company
  • 22.6. Becton, Dickinson and Company
  • 22.7. Bio-Rad Laboratories, Inc.
  • 22.8. Danaher Corporation
  • 22.9. Drawbridge Health, Inc.
  • 22.10. Greiner Bio-One International GmbH
  • 22.11. Nipro Corporation
  • 22.12. Poly Medicure Limited
  • 22.13. Radiometer Medical ApS
  • 22.14. Roche Diagnostics International AG
  • 22.15. Sarstedt AG & Co. KG
  • 22.16. Terumo Corporation
  • 22.17. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. UNITED STATES CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 17. CHINA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CAPILLARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CAPILLARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CAPILLARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FINGERSTICK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FINGERSTICK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FINGERSTICK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HEEL STICK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HEEL STICK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HEEL STICK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENIPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENIPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENIPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALIZED CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALIZED CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALIZED CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY INDEPENDENT LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY INDEPENDENT LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY INDEPENDENT LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NURSE AIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NURSE AIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NURSE AIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SELF MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SELF MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SELF MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALTY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALTY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALTY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CARDIAC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CARDIAC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CARDIAC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIABETES TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIABETES TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIABETES TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PREGNANCY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PREGNANCY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PREGNANCY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CORPORATE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CORPORATE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CORPORATE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVI